Société Générale — M&A Activity 2021

May 25, 2021

National Storage Mechanism | Additional information

RNS Number : 7195Z

Societe Generale SA

25 May 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	24/05/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	3,550,218	1.41	6,282	0.00
(2) Derivatives (other than options)	0	0.00	0	0.00
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	3,550,218	1.41	6,282	0.00

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	412	10.46
Purchase	1,017	10.49
Purchase	532	10.69
Purchase	1,016	10.69
Purchase	1,907,555	10.47
Sale	376	10.63
Sale	228	10.69
Sale	740	10.63
Sale	170	10.67
Sale	300	10.67
Sale	242	10.71
Sale	243	10.71
Sale	200	10.66
Sale	1,138	10.63
Sale	991	10.64
Sale	128	10.64
Sale	1,212	10.67
Sale	82	10.66
Sale	1,187	10.66
Sale	24	10.66
Sale	200	10.66
Sale	1,102	10.64
Sale	143	10.64
Sale	18	10.64
Sale	1,138	10.64
Sale	1,207	10.65
Sale	1,194	10.66
Sale	1,420	10.66
Sale	3,689	10.58
Sale	723	10.59
Sale	674	10.59
Sale	725	10.6
Sale	681	10.61
Sale	688	10.62
Sale	97	10.6
Sale	200	10.6
Sale	406	10.64
Sale	298	10.69
Sale	700	10.65
Sale	337	10.69
Sale	329	10.66
Sale	1,145	10.66
Sale	655	10.63
Sale	200	10.63
Sale	3,939	10.66
Sale	117	10.66
Sale	1,624	10.67
Sale	589	10.67
Sale	200	10.67
Sale	1,078	10.67
Sale	200	10.67
Sale	11	10.74
Sale	31	10.74
Sale	160	10.74
Sale	125	10.74
Sale	63	10.74
Sale	138	10.64
Sale	1,178	10.65
Sale	768	10.5
Sale	900	10.64
Sale	49	10.64
Sale	4,791	10.67
Sale	330	10.63
Sale	232	10.65
Sale	267	10.59
Sale	359	10.63
Sale	247	10.69
Sale	83	10.69
Sale	1,076	10.67
Sale	97	10.65
Total Purchases	1,910,532
Total Sales	43,882

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	25/05/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEAXSSALFFEEA